No abstract

The relationship between pain and increasing age was investigated using data from two different care settings collected on a province-wide basis in Ontario. Home care clients (HC) and complex continuing care patients (CCC) are assessed using the Resident Assessment Instrument-Home Care and Resident Assessment Instrument 2.0 instruments, respectively, as part of normal clinical practice. For this study, the sample was restricted to those aged 65 years and older and totaled 193,158 individuals. Centenarians (those 100 years of age or older) made up 0.41% (n=788) of the sample. Pain was assessed according to a previously validated pain scale embedded in both assessments that uses items on frequency and intensity. Based on 5-year age groups beginning at 65, the mean reported pain score was lower with each increment in age for men and women. Multiple logistic regression models were constructed and the odds ratios for pain in both HC and CCC groups decreased consistently in higher age groups after adjusting for disease diagnoses, cognition, functional status and health indicators. A model that included categories of analgesic medications coded based on the WHO pain ladder showed the relationship persisted after controlling for analgesia. In clinical settings, the oldest old appear to have lower levels of pain compared with the young old after adjusting for a variety of potential confounding variables.

No abstract

The objective of the study is assessment of the prevalence and type of hypertension in centenarians in Poland. The investigations included 92 people who had turned 100 years of age, who, within the protocol of the Project of Investigation Polish Centenarians, underwent genetic, anthropometric, psychological and sociological examinations, and whose cardiovascular system was assessed. In the present analysis, we are analysing data concerning their blood pressure (BP) assessed by several measurements (3-6) with the mercury sphygmomanometer on both arms in sitting (if possible) or lying position performed during one visit. Hypertension was diagnosed when average BP value exceeded X160/95 or X140/90 mmHg. The average of age was 101.2 years (range 100-111 years), the respective values for BP were: systolic 146.7 mmHg (99-213 mmHg), diastolic BP-80.3 mmHg (55-114 mmHg) and pulse pressure (PP) 66.4 mmHg (31-129 mmHg). Hypertension diagnosed based on the criterion X160/ 95 mmHg was found in 29% of subjects, and according to the recent WHO criterion (X140/90 mmHg) in 65% of subjects. PP exceeded 65 mmHg in 44.6%, and was above 50 mmHg in 91% subjects. In conclusion, hypertension occurs less frequently in centenarians, than in the entire population of old people, but it nevertheless cannot be considered a rare condition.

Major adverse cardiovascular events are closely associated with 24-hour blood pressure (BP). We determined outcome-driven thresholds for 24-hour mean arterial pressure (MAP), a BP index estimated by oscillometric devices. We assessed the association of major adverse cardiovascular events with 24-hour MAP, systolic BP (SBP), and diastolic BP (DBP) in a population-based cohort (n=11 596). Statistics included multivariable Cox regression and the generalized R 2 statistic to test model fit. Baseline office and 24-hour MAP averaged 97.4 and 90.4 mm Hg. Over 13.6 years (median), 2034 major adverse cardiovascular events occurred. Twenty-four-hour MAP levels of <90 (normotension, n=6183), 90 to <92 (elevated MAP, n=909), 92 to <96 (stage-1 hypertension, n=1544), and ≥96 (stage-2 hypertension, n=2960) mm Hg yielded equivalent 10-year major adverse cardiovascular events risks as office MAP categorized using 2017 American thresholds for office SBP and DBP. Compared with 24-hour MAP normotension, hazard ratios were 0.96 (95% CI, 0.80–1.16), 1.32 (1.15–1.51), and 1.77 (1.59–1.97), for elevated and stage-1 and stage-2 hypertensive MAP. On top of 24-hour MAP, higher 24-hour SBP increased, whereas higher 24-hour DBP attenuated risk ( P <0.001). Considering the 24-hour measurements, R 2 statistics were similar for SBP (1.34) and MAP (1.28), lower for DBP than for MAP (0.47), and reduced to null, if the base model included SBP and DBP; if the ambulatory BP indexes were dichotomized according to the 2017 American guideline and the proposed 92 mm Hg for MAP, the R 2 values were 0.71, 0.89, 0.32, and 0.10, respectively. In conclusion, the clinical application of 24-hour MAP thresholds in conjunction with SBP and DBP refines risk estimates.